Medical Treatment AgreementMedical Treatment Agreement • March 18th, 2024
Contract Type FiledMarch 18th, 2024This agreement between (Patient) and Andrologix Health and Wellness, LLC. and their parent company Sozo Group, LLC (Andrologix) establishes guidelines and conditions required for the use of hormone replacement therapy (HRT) involving DEA "controlled" or "scheduled" medications. Andrologix and Patient agree that these guidelines and conditions are an essential factor in maintaining a successful patient/physician relationship. Adverse side effects and/or physical/psychological dependence may develop after repeated use of these medications and therefore, these agents are prescribed with caution.